Oxytocin in cesarean-sections. What's new?
Copyright © 2015 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved..
Oxytocin is the uterotonic agent of choice in the prevention and treatment of postpartum uterine atony. Nevertheless, there is no consensus on the optimal dose and rate for use in cesarean sections. The use of high bolus doses (e.g., 10IU of oxytocin) can determine deleterious cardiovascular changes for the patient, especially in situations of hypovolemia or low cardiac reserve. Furthermore, high doses of oxytocin for prolonged periods may lead to desensitization of oxytocin receptors in myometrium, resulting in clinical inefficiency.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:66 |
|---|---|
| Enthalten in: |
Brazilian journal of anesthesiology (Elsevier) - 66(2016), 4 vom: 10. Juli, Seite 402-7 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yamaguchi, Eduardo Tsuyoshi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
50-56-6 |
|---|
| Anmerkungen: |
Date Completed 14.07.2017 Date Revised 14.07.2017 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.bjane.2014.11.015 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM261756885 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM261756885 | ||
| 003 | DE-627 | ||
| 005 | 20231224200238.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bjane.2014.11.015 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0872.xml |
| 035 | |a (DE-627)NLM261756885 | ||
| 035 | |a (NLM)27343791 | ||
| 035 | |a (PII)S0104-0014(15)00113-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yamaguchi, Eduardo Tsuyoshi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Oxytocin in cesarean-sections. What's new? |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.07.2017 | ||
| 500 | |a Date Revised 14.07.2017 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2015 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved. | ||
| 520 | |a Oxytocin is the uterotonic agent of choice in the prevention and treatment of postpartum uterine atony. Nevertheless, there is no consensus on the optimal dose and rate for use in cesarean sections. The use of high bolus doses (e.g., 10IU of oxytocin) can determine deleterious cardiovascular changes for the patient, especially in situations of hypovolemia or low cardiac reserve. Furthermore, high doses of oxytocin for prolonged periods may lead to desensitization of oxytocin receptors in myometrium, resulting in clinical inefficiency | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Cesarean section | |
| 650 | 4 | |a Cesariana | |
| 650 | 4 | |a Desensitization | |
| 650 | 4 | |a Dessensibilização | |
| 650 | 4 | |a Dose | |
| 650 | 4 | |a Ocitocina | |
| 650 | 4 | |a Oxytocin | |
| 650 | 7 | |a Oxytocin |2 NLM | |
| 650 | 7 | |a 50-56-6 |2 NLM | |
| 700 | 1 | |a Siaulys, Mônica Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Torres, Marcelo Luis Abramides |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Brazilian journal of anesthesiology (Elsevier) |d 2013 |g 66(2016), 4 vom: 10. Juli, Seite 402-7 |w (DE-627)NLM225306182 |x 2352-2291 |7 nnns |
| 773 | 1 | 8 | |g volume:66 |g year:2016 |g number:4 |g day:10 |g month:07 |g pages:402-7 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bjane.2014.11.015 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 66 |j 2016 |e 4 |b 10 |c 07 |h 402-7 | ||